Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vitro

Currently viewing:

Administrative data

Endpoint:
in vitro gene mutation study in bacteria
Type of information:
experimental study
Adequacy of study:
key study
Study period:
13 Mar - 17 Apr 2012
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2012
Report date:
2012

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 471 (Bacterial Reverse Mutation Assay)
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Remarks:
Bayerisches Landesamt für Gesundheit und Lebensmittelsicherheit, Landesinstitut für Arbeitsschutz und Produktsicherheit, München, Germany
Type of assay:
bacterial reverse mutation assay

Test material

Constituent 1
Chemical structure
Reference substance name:
2-(3,4-dimethyl-1H-pyrazol-1-yl)butanedioic acid; 2-(4,5-dimethyl-1H-pyrazol-1-yl)butanedioic acid
EC Number:
940-877-5
Cas Number:
2241455-89-8
Molecular formula:
C9H12N2O4
IUPAC Name:
2-(3,4-dimethyl-1H-pyrazol-1-yl)butanedioic acid; 2-(4,5-dimethyl-1H-pyrazol-1-yl)butanedioic acid

Method

Target gene:
his operon
Species / strain
Species / strain / cell type:
S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and TA 102
Metabolic activation:
with and without
Metabolic activation system:
cofactor supplemented post-mitochondrial fraction (S9 mix), prepared from the livers of rats treated with phenobarbital and beta-naphthoflavone
Test concentrations with justification for top dose:
Pre-experiment: 3.16, 10, 31.6, 100, 316, 1000, 2500, 5000 µg/plate
Experiment 1 (standard plate test): 3.16, 10, 31.6, 100, 316, 1000, 2500, 5000 µg/plate
Experiment 2 (pre-incubation test): 3.16, 10, 31.6, 100, 316, 1000, 2500, 5000 µg/plate
Vehicle / solvent:
- Vehicle/solvent used: DMSO
Controls
Untreated negative controls:
yes
Negative solvent / vehicle controls:
yes
True negative controls:
no
Positive controls:
yes
Positive control substance:
other: without S9: sodium azide (TA 100, TA 1535); 4-nitro-o-phenylenediamine (TA 98; TA 1537); methylmethanesulfonate (TA 102); with S9: 2-aminoanthracene (all strains without TA102; TA 102)
Details on test system and experimental conditions:
METHOD OF APPLICATION: in agar (plate incorporation); preincubation

DURATION
- Preincubation period: 60 min
- Exposure duration: 48 h

NUMBER OF REPLICATIONS: triplicates each in two independent experiments

DETERMINATION OF CYTOTOXICITY
- Method: diminution of the background lawn or a reduction in the number of revertants

METABOLIC ACTIVATION SYSTEM:
The quality of the S9 homogenate was routinely tested in S. typhimurium using 2-aminoanthracene and benzo[a]pyrene
Evaluation criteria:
A test item is considered mutagenic if:
- a clear and dose-related increase in the number of revertants occurs and/or
- a biologically relevant positive response for at least one of the dose groups occurs in at least one tester strain with or without metabolic activation.
Biologically relevant means:
- number of reversion is at least twice the control (TA 98, TA 100, TA 102)
- number of reversion is at least thrice the control (TA 1535, TA 1537)
Statistics:
Mean and standard deviation (no. of revertant colonies)

Results and discussion

Test resultsopen allclose all
Key result
Species / strain:
S. typhimurium TA 1535
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Key result
Species / strain:
S. typhimurium TA 1537
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Key result
Species / strain:
S. typhimurium TA 98
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Key result
Species / strain:
S. typhimurium TA 100
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Key result
Species / strain:
S. typhimurium TA 102
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Additional information on results:
TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation: no precipitation was observed in any tester strain

RANGE-FINDING/SCREENING STUDIES:
No toxicity was observed in a range-finding assay (plate incorporation), tested up to 5000 µg/plate in TA 98 and TA 100.

COMPARISON WITH HISTORICAL CONTROL DATA:
The data were in accordance the historical control data.

Any other information on results incl. tables

Table 1: Test results of experiment 1 (standard plate test).

EXPERIMENT 1 (Standard Plate Test, SPT)

S9-Mix

Without

 

Test item (µg/plate)

TA 100

TA 1535

TA 98

TA 1537

TA 102

Water

142±34.9

32±2.5

28±2.5

8±4.0

270±20.0

Control (DMSO)

97±15.1

16±1.5

25±5.2

11±4.0

227±9.5

31.6

108±12.9

24±6.0

31±2.1

10±3.6

196±16.3

100

107±9.1

22±4.0

25±3.8

8±2.6

212±11.1

316

113±16.5

20±1.2

29±3.1

8±3.5

217±9.8

1000

103±3.2

19±3.8

21±8.7

10±3.2

234±19.5

2500

111±19.7

21±2.1

18±5.1

7±2.1

219±9.1

5000

103±11.0

16±1.7

24±6.1

10±3.2

225±4.9

NOPD (10 µg)

-

-

424±34.8

86±10.5

-

NaN3 (10 µg)

1006±78.6

962±52.5

-

-

-

MMS (1 µL)

-

-

-

-

946±306.0

 

 

 

 

 

 

S9-Mix

With

 

 

 

 

 

 

Test item (µg/plate)

TA 100

TA 1535

TA 98

TA 1537

TA 102

Water

129±12.5

25±1.5

34±2.1

13±2.6

309±31.2

NC (DMSO)

123±3.6

26±2.3

22±9.6

8±1.7

259±11.0

31.6

123±5.5

24±6.4

30±4.6

8±1.7

263±39.7

100

120±7.9

26±1.7

27±2.9

10±5.5

277±13.2

316

117±18.9

20±4.6

31±4.7

11±1.7

249±20.5

1000

119±9.1

23±2.6

27±4.6

10±2.3

241±21.8

2500

118±19.6

28±2.6

28±3.6

11±2.1

279±10.1

5000

108±0.7

20±4.0

33±10.6

8±3.8

275±13.3

2-AA (2.5 µg)

1808±119.8

166±17.5

3160±201.7

375±11.0

547±68.7

 

Table 2: Test results of experiment 2 (preincubation assay).

EXPERIMENT 2 (preincubation assay)

S9-Mix

Without

 

Test item (µg/plate)

TA 100

TA 1535

TA 98

TA 1537

TA 102

Water

135±7.6

16±2.5

26±9.0

6±2.9

287±14.9

Control (DMSO)

126±9.5

12±3.2

18±1.0

5±2.3

221±2.5

31.6

92±6.7

17±3.1

21±3.5

8±3.5

238±14.2

100

116±25.4

13±3.2

19±6.1

9±3.5

254±4.9

316

98±12.1

12±4.7

21±1.5

5±1.5

229±12.2

1000

100±12.5

12±1.5

23±6.0

6±1.2

248±13.7

2500

101±5.1

14±5.1

22±4.0

5±5.1

258±33.2

5000

100±14.2

16±2.9

22±2.9

5±2.9

255±28.0

NOPD (10 µg)

-

-

470±35.9

61±30.3

-

NaN3 (10 µg)

1065±64.5

1152±105.1

-

-

-

MMS (1 µL)

-

-

-

-

1851±10.4

S9-Mix

With

 

 

 

 

 

 

Test item (µg/plate)

TA 100

TA 1535

TA 98

TA 1537

TA 102

Water

166±6.7

11±4.6

23±1.5

11±1.7

412±11.6

NC (DMSO)

130±0.0

10±1.2

32±2.0

5±3.1

323±6.1

31.6

146±13.7

14±4.6

33±4.5

5±2.0

296±15.0

100

146±7.8

11±3.6

28±7.8

5±1.0

303±44.8

316

121±20.6

17±4.6

25±5.7

4±0.6

310±12.1

1000

132±4.7

12±3.5

25±2.5

7±0.0

298±17.7

2500

149±9.5

10±2.3

34±2.5

6±2.1

309±26.6

5000

139±3.5

10±4.9

20±2.9

6±2.1

319±42.2

2-AA (2.5 µg)

2208±69.0

194±17.5

1949±348.5

186±30.4

671±23.7

 

Applicant's summary and conclusion

Conclusions:
Interpretation of results:
negative